Mabnus_bio·Sep 22Literature share antibody sequences defined a new target for osteosarcoma CAR-T therapyOsteosarcoma (OS) remains a frustrating malignancy in children and young adults, with a dismal prognosis for metastatic and recurrent…
Dr. Akshita Puri Bajaj·Sep 2Indigenous CAR-T cell therapy: Clinical evidence to real world impactIn my earlier blog, “Living Drug: A Ray of Hope for Cancer Patients and Caregivers”, I explored the transformative potential of CAR-T cell…
QuarkAndCode·Feb 6Cell Therapy: Stem Cells, CAR‑T & Scaling Living MedicinesDiscover cell therapy — living medicines like stem cells and CAR-T — plus the manufacturing hurdles and solutions driving global access…
Tatsuro Chiyoya·Oct 7, 2025From Systemic Toxicity to Precision Immunity: The PD-L1–IL-12 Fusion Platform That Turns CAR-T…https://www.nature.com/articles/s41551-025-01509-2
Sophia Dhami·Dec 10, 2024Overcoming the Challenges of CAR-T Therapy: Tackling Its LimitationsCAR-T therapy has changed the game for cancer treatment, but it’s not perfect yet. There are still some hurdles to jump, like side effects…
